Impact of severe adverse events during second-line therapy on healthcare costs in patients with advanced non-small cell lung cancer (aNSCLC)

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2016-10, Vol.27, p.vi424-vi424
Hauptverfasser:	Yim, Y.M., Gandhi, M., Guerin, A., Ionescu-Ittu, R., Pivneva, I., Shi, S., Wu, E.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	vi424
container_issue
container_start_page	vi424
container_title	Annals of oncology
container_volume	27
creator	Yim, Y.M. Gandhi, M. Guerin, A. Ionescu-Ittu, R. Pivneva, I. Shi, S. Wu, E.
description
doi_str_mv	10.1093/annonc/mdw383.27
format	Article
fullrecord	<record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdw383_27</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419448503</els_id><sourcerecordid>S0923753419448503</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2747-2cb74d1b0ab0473ca44757c3404dca319dc2a884f17f6a9eca830349b847a5f93</originalsourceid><addsrcrecordid>eNp1kD9PwzAQxS0EEqWwM3qEIa0dO3XMhiL-VKpgAObocnaoUepUdtqq34EPjUtZWe50uvs9vXuEXHM24UyLKXjfe5yuzE6UYpKrEzLixUxnJZP8lIyYzkWmCiHPyUWMX4yxmc71iHzPV2vAgfYtjXZrg6VgUouWpskPkZpNcP4zLbH3Juuct3RY2gDrPe09XVrohiVC4rCP6dx5uobB_aI7NywPcuDRGprsZXEFXUfRptJtkioeVoHewMtbtahuL8lZC120V399TD4eH96r52zx-jSv7hcZ5kqqLMdGScMbBg2TSiBIqQqFQjJpEATXBnMoS9ly1c5AW4RSMCF1U0oFRavFmLCjLoY-xmDbeh3cCsK-5qw-pFkf06yPada5SsjdEbHJ19bZUEdMX6bHXLA41KZ3_8M_dp-Bug</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Impact of severe adverse events during second-line therapy on healthcare costs in patients with advanced non-small cell lung cancer (aNSCLC)</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Yim, Y.M. ; Gandhi, M. ; Guerin, A. ; Ionescu-Ittu, R. ; Pivneva, I. ; Shi, S. ; Wu, E.</creator><creatorcontrib>Yim, Y.M. ; Gandhi, M. ; Guerin, A. ; Ionescu-Ittu, R. ; Pivneva, I. ; Shi, S. ; Wu, E.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdw383.27</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Annals of oncology, 2016-10, Vol.27, p.vi424-vi424</ispartof><rights>2016 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Yim, Y.M.</creatorcontrib><creatorcontrib>Gandhi, M.</creatorcontrib><creatorcontrib>Guerin, A.</creatorcontrib><creatorcontrib>Ionescu-Ittu, R.</creatorcontrib><creatorcontrib>Pivneva, I.</creatorcontrib><creatorcontrib>Shi, S.</creatorcontrib><creatorcontrib>Wu, E.</creatorcontrib><title>Impact of severe adverse events during second-line therapy on healthcare costs in patients with advanced non-small cell lung cancer (aNSCLC)</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp1kD9PwzAQxS0EEqWwM3qEIa0dO3XMhiL-VKpgAObocnaoUepUdtqq34EPjUtZWe50uvs9vXuEXHM24UyLKXjfe5yuzE6UYpKrEzLixUxnJZP8lIyYzkWmCiHPyUWMX4yxmc71iHzPV2vAgfYtjXZrg6VgUouWpskPkZpNcP4zLbH3Juuct3RY2gDrPe09XVrohiVC4rCP6dx5uobB_aI7NywPcuDRGprsZXEFXUfRptJtkioeVoHewMtbtahuL8lZC120V399TD4eH96r52zx-jSv7hcZ5kqqLMdGScMbBg2TSiBIqQqFQjJpEATXBnMoS9ly1c5AW4RSMCF1U0oFRavFmLCjLoY-xmDbeh3cCsK-5qw-pFkf06yPada5SsjdEbHJ19bZUEdMX6bHXLA41KZ3_8M_dp-Bug</recordid><startdate>20161001</startdate><enddate>20161001</enddate><creator>Yim, Y.M.</creator><creator>Gandhi, M.</creator><creator>Guerin, A.</creator><creator>Ionescu-Ittu, R.</creator><creator>Pivneva, I.</creator><creator>Shi, S.</creator><creator>Wu, E.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20161001</creationdate><title>Impact of severe adverse events during second-line therapy on healthcare costs in patients with advanced non-small cell lung cancer (aNSCLC)</title><author>Yim, Y.M. ; Gandhi, M. ; Guerin, A. ; Ionescu-Ittu, R. ; Pivneva, I. ; Shi, S. ; Wu, E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2747-2cb74d1b0ab0473ca44757c3404dca319dc2a884f17f6a9eca830349b847a5f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yim, Y.M.</creatorcontrib><creatorcontrib>Gandhi, M.</creatorcontrib><creatorcontrib>Guerin, A.</creatorcontrib><creatorcontrib>Ionescu-Ittu, R.</creatorcontrib><creatorcontrib>Pivneva, I.</creatorcontrib><creatorcontrib>Shi, S.</creatorcontrib><creatorcontrib>Wu, E.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yim, Y.M.</au><au>Gandhi, M.</au><au>Guerin, A.</au><au>Ionescu-Ittu, R.</au><au>Pivneva, I.</au><au>Shi, S.</au><au>Wu, E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of severe adverse events during second-line therapy on healthcare costs in patients with advanced non-small cell lung cancer (aNSCLC)</atitle><jtitle>Annals of oncology</jtitle><date>2016-10-01</date><risdate>2016</risdate><volume>27</volume><spage>vi424</spage><epage>vi424</epage><pages>vi424-vi424</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Elsevier Ltd</pub><doi>10.1093/annonc/mdw383.27</doi><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0923-7534
ispartof	Annals of oncology, 2016-10, Vol.27, p.vi424-vi424
issn	0923-7534 1569-8041
language	eng
recordid	cdi_crossref_primary_10_1093_annonc_mdw383_27
source	EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title	Impact of severe adverse events during second-line therapy on healthcare costs in patients with advanced non-small cell lung cancer (aNSCLC)
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T03%3A46%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20severe%20adverse%20events%20during%20second-line%20therapy%20on%20healthcare%20costs%20in%20patients%20with%20advanced%20non-small%20cell%20lung%20cancer%20(aNSCLC)&rft.jtitle=Annals%20of%20oncology&rft.au=Yim,%20Y.M.&rft.date=2016-10-01&rft.volume=27&rft.spage=vi424&rft.epage=vi424&rft.pages=vi424-vi424&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdw383.27&rft_dat=%3Celsevier_cross%3ES0923753419448503%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0923753419448503&rfr_iscdi=true